St. Jude Medical Announces Japanese Approval of the Angio-Seal STS Plus Vascular Closure Device (Business Wire via Yahoo!7 Finance)
St. Jude Medical, Inc. (NYSE:STJ) today announced regulatory approval from the Ministry of Health, Labor and Welfare (MHLW), in addition to reimbursement approval, for the Angio-Seal(TM) STS Plus Vascular Closure device.